Human papillomavirus: clinical manifestations and prevention
- PMID: 21121531
Human papillomavirus: clinical manifestations and prevention
Abstract
Human papillomaviruses cause the most common sexually transmitted infection in the world and are responsible for nearly all cases of cervical cancer. Genital human papillomavirus infection can be divided into low-risk infections (causing genital warts) and high-risk infections (causing cervical intraepithelial neoplasia, and cervical and other cancers). Exposure to human papilloma- virus typically produces a sexually transmitted infection that may progress to a clinically apparent process, such as genital warts and cervical intraepithelial neoplasia lesions of the lower genital tract. Although most human papillomavirus infections resolve spontaneously within two years, some high-risk infections persist and are considered cancer precursors. Risk factors for persistent infection include multiple sex partners, sex at an early age, history of sexually transmitted infections, and smoking. Condom use is only partially protective against human papillomavirus infection. The two human papillomavirus vaccines are most effective if given to girls before the onset of sexual activity.
Summary for patients in
-
How to prevent cervical cancer.Am Fam Physician. 2010 Nov 15;82(10):1217. Am Fam Physician. 2010. PMID: 21121532 No abstract available.
Similar articles
-
An update on barriers to adolescent human papillomavirus vaccination in the USA.Expert Rev Vaccines. 2015;14(10):1377-84. doi: 10.1586/14760584.2015.1078240. Epub 2015 Aug 13. Expert Rev Vaccines. 2015. PMID: 26292763 Review.
-
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.J Natl Cancer Inst. 2010 Mar 3;102(5):325-39. doi: 10.1093/jnci/djp534. Epub 2010 Feb 5. J Natl Cancer Inst. 2010. PMID: 20139221 Clinical Trial.
-
Prevention of human papilloma virus infection with vaccines.J Pak Med Assoc. 2010 Aug;60(8):676-81. J Pak Med Assoc. 2010. PMID: 20726203 Review.
-
Spectrum of genital human papillomavirus infection in a female adolescent population.Sex Transm Dis. 1995 Jul-Aug;22(4):236-43. doi: 10.1097/00007435-199507000-00007. Sex Transm Dis. 1995. PMID: 7482107
-
High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys.Dermatol Ther. 2017 Jan;30(1). doi: 10.1111/dth.12435. Epub 2016 Oct 9. Dermatol Ther. 2017. PMID: 27723194
Cited by
-
Novel prognostic nomograms in cervical cancer based on analysis of 1075 patients.Cancer Med. 2023 Mar;12(5):6092-6104. doi: 10.1002/cam4.5335. Epub 2022 Nov 16. Cancer Med. 2023. PMID: 36394197 Free PMC article. Clinical Trial.
-
Human Papillomavirus Infection during Pregnancy and Childhood: A Comprehensive Review.Microorganisms. 2022 Sep 28;10(10):1932. doi: 10.3390/microorganisms10101932. Microorganisms. 2022. PMID: 36296208 Free PMC article. Review.
-
Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection.Front Cell Infect Microbiol. 2022 Jul 7;12:927131. doi: 10.3389/fcimb.2022.927131. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35873158 Free PMC article. Review.
-
Success of Intralesional Purified Protein Derivative Immunotherapy in the Treatment of Anogenital Warts: A Case Report.J Exp Pharmacol. 2022 Apr 4;14:131-135. doi: 10.2147/JEP.S347241. eCollection 2022. J Exp Pharmacol. 2022. PMID: 35401016 Free PMC article.
-
Clinical and pathological aspects of condyloma acuminatum - review of literature and case presentation.Rom J Morphol Embryol. 2021 Apr-Jun;62(2):369-383. doi: 10.47162/RJME.62.2.03. Rom J Morphol Embryol. 2021. PMID: 35024725 Free PMC article. Review.
